LGALS3 and pulmonary arterial hypertension: In pulmonary hypertension, Gal-3 activates the AKT signaling pathway to overactivate pulmonary vascular adventitial fibroblasts, promoting the occurrence and development of PAH (pulmonary arterial hypertension) (Barman et al., 2019).